SyntheticMR
Dustin DeRosier serves as Vice President Sales for North America at SyntheticMR, overseeing sales strategy and operations to enhance growth and access to AI-powered MRI solutions since January 2025. Prior to this role, DeRosier led sales efforts at Combinostics for an AI SaaS solution aimed at neurological disorders from June 2024 to January 2025. Previous experience includes serving as Director of Sales and Strategic Initiatives at Cortechs.ai, focusing on direct sales and partnerships, and as Sales Director at Verata Health, where business development and account management were core responsibilities. DeRosier also held the position of Business Development Manager for medical devices at Element Materials Technology, consistently surpassing sales goals. DeRosier holds a Bachelor of Arts in Biological and Biomedical Sciences from St. Cloud State University.
This person is not in any teams
This person is not in any offices
SyntheticMR
SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI) that supports a faster and more precise diagnosis of patients worldwide. Join us for the latest updates on news, events and clinical research involving our products. SyntheticMR’s unique SyMRI technology measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single fast scan. SyMRI is designed to help you save valuable time by reducing scan time, all the while aiding as an objective decision support for diagnosis and patient follow-ups. SyMRI offers a fast and standardized protocol with clinically relevant quantitative data for more robust assessments of patients. SyntheticMR AB is headquartered in Linköping, Sweden with sales representation in the USA, Japan and India. The company was founded in 2007 and is listed on the AktieTorget exchange in Stockholm, Sweden.